Monteplase
drug drugOn this page
Also known as CleactorMonteplasa
Summary
Monteplase (CHEMBL2108426) is a phase-3 clinical-stage enzyme.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Enzyme
- Clinical trials: 1
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108426 |
| Name | Monteplase |
| Type | Enzyme |
| Max phase | 3 |
Also known as: Cleactor, Monteplasa, Monteplase, MONTEPLASE
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 1.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE4 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00442234 | PHASE4 | COMPLETED | Post-marketing Study of Monteplase (Cleactor) in Patients With Acute Pulmonary Embolism |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.